The Balanced Investor Club

Drug Manufacturers General Industry Analysis

22 companies analyzed • Returns from -113.9% to +349.1% • Data through Mar 19, 2026

Company List (22 Results)

View:
Sort:

Industry Performance

(22/22 companies)
2025-03-21 → 2026-03-19
Weighted Avg
+13.5%
Best
+349.1%
Worst
-113.9%
Returns Distribution
Top 5
1. AMRN+349.1%2. SCLX+332.7%3. AZN+92.5%4. JNJ+37.3%5. SCLXW+35.9%
Bottom 5
1. NSRX-113.9%2. OGN-89.9%3. NVO-72.9%4. MIRA-22.7%5. SNY-22.7%

AMRN

+349.1%

Amarin Corporation PLC

SCLX

+332.7%

Scilex Holding Company

AZN

+92.5%

AstraZeneca PLC ADR

JNJ

+37.3%

Johnson & Johnson

SCLXW

+35.9%

Scilex Holding Company

GSK

+28.9%

GlaxoSmithKline PLC ADR

NVS

+27.9%

Novartis AG ADR

GILD

+27.6%

Gilead Sciences Inc

BIIB

+26.4%

Biogen Inc

MRK

+20.4%

Merck & Company Inc

AMGN

+10.2%

Amgen Inc

LLY

+9.1%

Eli Lilly and Company

PFE

+4.3%

Pfizer Inc

GRFS

-0.3%

Grifols SA ADR

ABBV

-1.8%

AbbVie Inc

MDCXW

-2.9%

Medicus Pharma Ltd. Warrant

BMY

-4.9%

Bristol-Myers Squibb Company

MIRA

-22.7%

MIRA Pharmaceuticals, Inc. Common Stock

SNY

-22.7%

Sanofi ADR

NVO

-72.9%

Novo Nordisk A/S

1–20 of 22
Page 1 of 2
Methodology

The Weighted Average return (+13.5%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

19 companies with market cap data included: AMRN, SCLX, AZN, JNJ, GSK, NVS, GILD, BIIB, MRK, AMGN and 9 more...

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer